Johnson & Johnson on 6 April 2016,announced the official launch of its global public health strategy at the opening of its companies on-the-ground global public health operations in Cape Town, South Africa.
Through this global strategy, Johnson & Johnson will mobilize its global public health capabilities and resources behind a unified, multidisciplinary effort to deliver a sustainable, measurable impact against significant public health needs.
“Public health in the developing world faces enormous challenges that require unique solutions, and by engaging, enabling and empowering local health care professionals and entrepreneurs in this way, we can advance the research, development and distribution of new medicines and treatments that will make a difference for patients in Africa,” says Alex Gorsky, Johnson & Johnson Chairman and Chief Executive Officer.
“Ultimately, we’re aspiring to build a healthy world free of disease, and our approach here is a potential blueprint for helping us and others succeed against that broader, global goal in the future.”
“This is a model based on innovation, collaboration, and local empowerment that aims to address life threatening issues and deliver measurable results to improve outcomes for patients, families and communities, first across Africa, and more globally in the longer term,” says Paul Stoffels, Johnson & Johnson Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals.
“By directly engaging with and empowering researchers and the health care community across South Africa, we will be better able to direct our resources and advance innovations that can lead to greater impact. We think this can work anywhere in the world, but our urgency right now has to be in Africa because of the patients’ needs.”
“Local capacity building and empowerment are key aspects of this new approach and are critical to achieving sustainable outcomes,” says Jaak Peeters, Head of Johnson & Johnson’s global public health organization.
“Our sights are set on achieving meaningful long-term results, such as eliminating multi-drug resistant TB or providing adolescent girls with tools they need to stay HIV-free and by working with local and global partners, we can create an ecosystem where we can help achieve those goals.”
“We’ve learned over time that solving last-mile challenges through local empowerment and partnerships offers the greatest potential impact in the fight against public health challenges, and that it can also help fuel the local economy and catalyze infrastructure investments,” says Alma Scott, Vice President of Global Operations and Partnerships for Johnson & Johnson’s global public health organization.